STAT5A and acute lymphoblastic leukemia: Amongst others, ALL, myeloproliferative neoplasms, AML, chronic myeloid leukemia (CML), B-ALL, and peripheral T cell leukemia/lymphoma (PTCL) show enhanced STAT5A/B signaling [129,130].